News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HepaLife Technologies Inc. (HPLF.OB) to Enter Pain Management Market with Its Transdermal Patch



11/3/2010 11:34:17 AM

NEW YORK--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (“HepaLife”), an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, today announced its intention to pursue the development of a transdermal pain patch. HepaLife’s subsidiary, Alliqua BioMedical, Inc. (“Alliqua”), recently retained Jeiven Pharmaceutical Consulting, Inc. (“Jeiven”) to assist it in this new product development.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES